LD-2 disclosure · 3rd Quarter - Report
REGENERON PHARMACEUTICALS, INC
Client
- Location
- New York · United States of America
Registrant
- Description
- Biopharmaceutical development and manufacturing
- Location
- TARRYTOWN, New York, United States of America
Lobbying activities
3 issuesHealth Issues
Biodefense, FDA, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; issues relating to the Inflation Reduction Act; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023; S.954 - Affordable Insulin Now Act of 2023; issues relating to the Prescription Drug User Fee Act; issues relating to infectious disease education; issues relating to the Pandemic and All-Hazards Preparedness reauthorization; Biomedical Advanced Research and Development Authority contract; issues relating to step therapy
LobbyistsMAYA BERMINGHAM · VALERIE VOLPE · KATHERINE HADDAD · MADDIE DAVIDSON · EBEN DUROSS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers
LobbyistsVALERIE VOLPE · KATHERINE HADDAD · MADDIE DAVIDSON · EBEN DUROSS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Patent issues relating to biopharmaceutical manufacturers; intellectual property rights; issues relating to WTO TRIPS waivers
LobbyistsVALERIE VOLPE · MADDIE DAVIDSON · EBEN DUROSS